REVIEW   

Minerva Psichiatrica 2014 December;55(4):161-80

Copyright © 2014 EDIZIONI MINERVA MEDICA

lingua: Inglese

Pharmacological and behavioral management of Tourette disorder and chronic tic disorders

Mcguire J. F. ^{1, 2}, Hanks C. E. ², Mcguire J. F. ³, Murphy T. K. ^{2, 4}, Lewin A. B. ^{2, 4}, Storch E. A. ^{1, 2, 4, 5, 6}

¹ Department of Psychology, University of South Florida, Tampa, FL, USA; ² Department of Pediatrics, University of South Florida, Tampa, FL, USA; ³ Department of Public Health, University of Arizona, Tucson, AZ, USA; ⁴ Departments of Psychiatry and Behavioral Neurosciences, University of South Florida, Tampa, FL, USA; ⁵ Rogers Behavioral Health, Tampa Bay, Tampa, FL, USA; ⁶ All Children’s Hospital, Johns Hopkins Medicine, Baltimore, MD, USA

Tourette disorder and chronic tic disorders (collectively referred to as CTDs) are neuropsychiatric conditions characterized by the presence of motor and/or phonic tics. CTDs affect between 0.8-2.0% of youth and have been associated with significant distress, impairment, and a poor quality of life. Effective and efficient treatments are needed for youth with CTDs to manage their tics and accompanying problems. This paper provides an overview of pharmacological and behavioral interventions for youth with CTDs that have been evaluated in randomized controlled trials. The paper concludes by highlighting future directions for treatment research pertinent for youth with CTDs.